AML, ADULT RECURRENT
Clinical trials for AML, ADULT RECURRENT explained in plain language.
Never miss a new study
Get alerted when new AML, ADULT RECURRENT trials appear
Sign up with your email to follow new studies for AML, ADULT RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cell therapy targets tough blood cancer in early trial
Disease control Recruiting nowThis early-phase study tests a new cell therapy called BSB-2002 in adults with a specific type of acute myeloid leukemia (AML) that has returned or not responded to at least two prior treatments. The main goal is to check the safety of BSB-2002 and see if it can help prevent the …
Matched conditions: AML, ADULT RECURRENT
Phase: PHASE1 • Sponsor: BlueSphere Bio, Inc • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
New cell therapy aims to stop blood cancers from coming back
Disease control Recruiting nowThis study tests a new treatment called BSB-1001 for people with certain blood cancers (AML, ALL, or MDS) who have had a stem cell transplant. The therapy uses specially modified immune cells to target and kill cancer cells while trying to avoid harming healthy tissue. The main g…
Matched conditions: AML, ADULT RECURRENT
Phase: PHASE1, PHASE2 • Sponsor: BlueSphere Bio, Inc • Aim: Disease control
Last updated May 13, 2026 15:59 UTC